The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Nicotine Dependence in Schizophrenia: Clinical Phenomena and Laboratory Findings
Abstract
OBJECTIVE: The goal of this report is to examine the potential implications of the high prevalence of smoking in schizophrenia for our understanding of this illness. METHOD: A selective review of the relevant clinical and preclinical literature was conducted. The authors present a review of the clinical observations about smoking in schizophrenia, summarize the preclinical data about the complexity of the CNS nicotinic receptor family, and examine the modulatory effects of nicotine on neurotransmitter systems implicated in schizophrenia. RESULTS: Clinical data suggest that smoking in schizophrenia may represent an attempt to self-medicate symptoms of the illness. Preclinical findings support a potential role of nicotine in medicating negative symptoms in particular. Recent preclinical and clinical data suggest that schizophrenic patients have a primary defect in the CNS nicotinergic system that leads to abnormal sensory gating. The complexity of the neuromodulatory effects of CNS nicotinic systems on other neurotransmitter systems underscores both the scope and potential importance of continued advancement of research in this area. CONCLUSIONS: Despite increasing clinical research focused on the extremely high prevalence of smoking in schizophrenia, linkages to the prodigious preclinical data about nicotine and nicotinic receptors are largely unexplored. These linkages are likely to be very important. Integrating nicotine use into our clinical and basic models of schizophrenia leads to a more complex but more realistic representation of brain dysfunction in this illness. Understanding how and why schizophrenic individuals use nicotine may lead to the development of new treatments for both schizophrenia and nicotine dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Hollmann, M., & Heinemann, S. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.000335 · Cited by 3,975
Dopamine in schizophrenia: a review and reconceptualization
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,018
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Carlsson, M., & Carlsson, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90108-m · Cited by 1,082
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058
Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022
Hippocampal synaptic transmission enhanced by low concentrations of nicotine
Gray, R., Rajan, A. S., Radcliffe, K. A., Yakehiro, M., & Dani, J. A. (1996) · Nature · doi:10.1038/383713a0 · Cited by 947
Cigarette smoking: implications for psychiatric illness
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.546 · Cited by 723
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats
Imperato, A., Mulas, A., & Di Chiara, G. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90629-1 · Cited by 693
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678
Inhibition of monoamine oxidase B in the brains of smokers
Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D., Wolf, A. P., et al. (1996) · Nature · doi:10.1038/379733a0 · Cited by 656
Meltzer, H. Y. (1989) · Psychopharmacology · doi:10.1007/bf00442554 · Cited by 602
Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1189 · Cited by 579
Nicotinic systems and cognitive function
Levin, E. D. (1992) · Psychopharmacology · doi:10.1007/bf02247415 · Cited by 514
Schizophrenia and smoking: an epidemiological survey in a state hospital
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.453 · Cited by 418
Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics
Adler, L. E., Hoffer, L. J., Griffith, J., Waldo, M. C., & Freedman, R. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90073-9 · Cited by 412
Nicotinic effects on the firing pattern of midbrain dopamine neurons
GRENHOFF, J., ASTON‐JONES, G., & SVENSSON, T. H. (1986) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1986.tb07988.x · Cited by 399
Le Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385
Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
Morens, D. M., Grandinetti, A., Reed, D., White, L. R., & Ross, G. W. (1995) · Neurology · doi:10.1212/wnl.45.6.1041 · Cited by 370
Nicotine-Haloperidol Interactions and Cognitive Performance in Schizophrenics
Levin, E. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00018-8 · Cited by 342
Schizophrenia: A Subcortical Neurotransmitter Imbalance Syndrome?
Carlsson, M., & Carlsson, A. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.425 · Cited by 341
Clarke, P. B., Fu, D. S., Jakubovic, A., & Fibiger, H. C. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22152-8 · Cited by 318
Nicotine Dependence and Schizophrenia
Ziedonis, D. M., Kosten, T. R., Glazer, W. M., & Frances, R. J. (1994) · Psychiatric Services · doi:10.1176/ps.45.3.204 · Cited by 302
Ziedonis, D. M., & George, T. P. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.2.247 · Cited by 278
Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine
Mereu, G., Yoon, K.-W. P., Boi, V., Gessa, G. L., Naes, L., & Westfall, T. C. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90556-5 · Cited by 273
How to Examine Patients Using the Abnormal Involuntary Movement Scale
Munetz, M. R., & Benjamin, S. (1988) · Psychiatric Services · doi:10.1176/ps.39.11.1172 · Cited by 263
Nicotinic Receptor Function in Schizophrenia
Leonard, S., Adams, C., Breese, C. R., Adler, L. E., Bickford, P., Byerley, W., Coon, H., Griffith, J. M., Miller, C., Myles-Worsley, M., et al. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.431 · Cited by 262
Olincy, A., Young, D. A., & Freedman, R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00302-2 · Cited by 252
Vidal, C., & Changeux, J.-P. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90558-w · Cited by 240
Haloperidol increases smoking in patients with schizophrenia
McEvoy, J. P., Freudenreich, O., Levin, E. D., & Rose, J. E. (1995) · Psychopharmacology · doi:10.1007/bf02246063 · Cited by 225
Gating of auditory P50 in schizophrenics: Unique effects of clozapine
Nagamoto, H. T., Adler, L. E., Hea, R. A., Griffith, J. M., McRae, K. A., & Freedman, R. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00371-1 · Cited by 201
Tsuang, M. T. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780220017001 · Cited by 197
Clozapine decreases smoking in patients with chronic schizophrenia
McEvoy, J., Freudenreich, O., McGee, M., Vanderzwaag, C., Levin, E., & Rose, J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00365-a · Cited by 195
Mortality in Schizophrenia: A Ten-Year Follow-up Based on the Stockholm County Inpatient Register
Allebeck, P. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800070036005 · Cited by 183
Effects of clozapine on smoking in chronic schizophrenic outpatients.
George, T. P., Sernyak, M. J., Ziedonis, D. M., & Woods, S. W. (1995) · PubMed · Cited by 179
Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers
Glassman, A. H., Covey, L. S., Dalack, G. W., Stetner, F., Rivelli, S. K., Fleiss, J., & Cooper, T. B. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.205 · Cited by 168
Self-citationNisell, M., Nomikos, G. G., Hertel, P., Panagis, G., & Svensson, T. H. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199604)22:4<369::aid-syn8>3.0.co;2-9 · Cited by 158
Pauly, J. R., Marks, M. J., Gross, S. D., & Collins, A. C. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20464-5 · Cited by 152
Nicotinic acetylcholine receptor subtypes in human frontal cortex: Changes in Alzheimer's disease
Sugaya, K., Giacobini, E., & Chiappinelli, V. A. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270314 · Cited by 152
Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders
Diwan, A., Castine, M., Pomerleau, C. S., Meador-Woodruff, J. H., & Dalack, G. W. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00045-0 · Cited by 152
Self-citationSmoking and Malignancy in Schizophrenia
Masterson, E. L., & O’Shea, B. (1984) · The British Journal of Psychiatry · doi:10.1192/bjp.145.4.429 · Cited by 151
Distribution of Nicotinic Receptors in the Human Hippocampus and Thalamus
Rubboli, F., COURT, J. A., Sala, C., Morris, C. M., Chini, B., Perry, E. K., & Clementi, F. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00550.x · Cited by 148
Mortality and causes of death in schizophrenic patients in Denmark
Mortensen, P. B., & Juel, K. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05466.x · Cited by 138
Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients
D, A. O. M. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00095-x · Cited by 136
Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature
Dalack, G. W., & Meador‐Woodruff, J. H. (1996) · Schizophrenia Research · doi:10.1016/s0920-9964(96)80441-5 · Cited by 135
Self-citationThe time course of information-processing deficits in schizophrenia
BRAFF, D. L., & Saccuzzo, D. P. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.2.170 · Cited by 134
Codistribution of a sensory gating deficit and schizophrenia in multi-affected families
Waldo, M. C., Carey, G., Myles‐Worsley, M., Cawthra, E. M., Adler, L. E., Nagamoto, H. T., Wender, P. H., Byerley, W., Plaetke, R., & Freedman, R. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90092-4 · Cited by 129
Jann, M. W., Saklad, S. R., Ereshefsky, L., Richards, A. L., Harrington, C. A., & Davis, C. M. (1986) · Psychopharmacology · doi:10.1007/bf00174062 · Cited by 123
Linking the Family of D2 Receptors to Neuronal Circuits in Human Brain: Insights into Schizophrenia
Joyce, J. N. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00276-x · Cited by 123
Nicotine exposure and tardive dyskinesia
YASSA, R., Lal, S., Korpassy, A., & Ally, J. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90131-4 · Cited by 119
Effects of smoking on fluphenazine clearance in psychiatric inpatients
Ereshefsky, L., Jann, M. W., Saklad, S. R., Davis, C. M., Richards, A. L., & BURCH, N. R. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90063-0 · Cited by 118
Alkondon, M., Reinhardt, S., Lobron, C., Hermsen, B., Maelicke, A., & Albuquerque, E. X. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22712-4 · Cited by 113
Readiness to Stop Smoking in Schizophrenia
Addington, J., el‐Guebaly, N., Addington, D. E., & Hodgins, D. C. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200107 · Cited by 112
Addictive behaviors among hospitalized psychiatric patients
O’Farrell, T. J., Connors, G. J., & Upper, D. (1983) · Addictive Behaviors · doi:10.1016/0306-4603(83)90032-1 · Cited by 111
Cigarette smoking and neuroleptic-induced parkinsonism
Decina, P., Caracci, G., Sandik, R., Berman, W., Mukherjee, S., & Scapicchio, P. L. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90483-i · Cited by 108
Covey, L. S., Hughes, D. C., Glassman, A. H., Blazer, D. G., & George, L. K. (1994) · Tobacco Control · doi:10.1136/tc.3.3.222 · Cited by 105
Sanderson, E. M., Drasdo, A. L., McCrea, K. E., & Wonnacott, S. (1993) · Brain Research · doi:10.1016/0006-8993(93)91104-z · Cited by 105
Nicotine intake in smokers increases following a single dose of haloperidol
Dawe, S., Gray, J. A., Russell, M. A., & Gerda, C. (1995) · Psychopharmacology · doi:10.1007/bf02245105 · Cited by 103
Vezina, P., Blanc, G., Glowinski, J., & Tassin, J. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11064-1 · Cited by 101
Jackson, M. B. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017019 · Cited by 97
Regional variation in the effects of nicotine on catecholamine overflow in rat brain
Benwell, M. E. M., & Balfour, D. J. K. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00101-5 · Cited by 94
Smoking and movement disorders in psychiatric patients
Menza, M. A., Grossman, N., Horn, M. V., Cody, R., & Forman, N. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90163-g · Cited by 93
Formation of Oligomers Containing the β3 and β4 Subunits of the Rat Nicotinic Receptor
Forsayeth, J., & Kobrin, E. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01531.1997 · Cited by 92
The Biochemical Basis of Neuropharmacology, 7th ed
Ebert, M. H., & Chengappa, K. N. R. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0510b · Cited by 91
Kirch, D. G., Gerhardt, G. A., Shelton, R. C., Freedman, R., & Wyatt, R. J. (1987) · Clinical Neuropharmacology · doi:10.1097/00002826-198708000-00009 · Cited by 89
Morbidity and mortality in tardive dyskinesia: associations in chronic schizophrenia
Youssef, H. A., & Waddington, J. L. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02754.x · Cited by 88
Alcohol, Cannabis, Nicotine, and Caffeine Use and Symptom Distress in Schizophrenia
Hamera, E. K., Schneider, J. K., & DeViney, S. (1995) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199509000-00001 · Cited by 81
Collins, A. C., Romm, E., & Wehner, J. M. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90222-l · Cited by 79
Dw, S., Loring, R., Aizenman, E., & Zigmond, R. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-01-00287.1991 · Cited by 78
Andersson, K., Fuxé, K., & Agnati, L. F. (1981) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1981.tb06827.x · Cited by 78
Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats
Whiteaker, P., Garcha, H. S., Wonnacott, S., & Stolerman, I. P. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16417.x · Cited by 70
Level of Functioning, Severity of Illness, and Smoking Status Among Chronic Psychiatric Patients
Hall, R. G., DUHAMEL, M., MCCLANAHAN, R., MILES, G., NASON, C., ROSEN, S., SCHILLER, P., TAO-YONENAGA, L., & Hall, S. M. (1995) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199507000-00008 · Cited by 68
Sandyk, R. (1993) · International Journal of Neuroscience · doi:10.3109/00207459309000574 · Cited by 60
Glynn, S. M., & Sussman, S. Y. (1990) · Psychiatric Services · doi:10.1176/ps.41.9.1027 · Cited by 59
Nilsson, A., Waller, L., Rosengren, A., Adlerberth, A., & Wilhelmsen, L. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00289-2 · Cited by 58
Bickford, P. C., & Wear, K. D. (1995) · Brain Research · doi:10.1016/0006-8993(95)01157-9 · Cited by 55
Quantitative autoradiography of nicotinic receptors in large cryosections of human brain hemispheres
Adem, A., Nordberg, A. K., Jossan, S. S., Sara, V. R., & Gillberg, P. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90540-5 · Cited by 52
Buda, M., Tsuang, M. T., & Fleming, J. A. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800270101012 · Cited by 48
Perry, E. K., COURT, J. A., Johnson, M., Piggott, M. A., & Perry, R. H. (1992) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(92)90056-v · Cited by 46
Brief Communication: Tobacco Addiction as a Marker of Age at Onset of Schizophrenia
Sandyk, R., & Kay, S. R. (1991) · International Journal of Neuroscience · doi:10.3109/00207459109150699 · Cited by 43
Smoking in Chronic Schizophrenia
Gopalaswamy, A. K., & Morgan, R. (1986) · The British Journal of Psychiatry · doi:10.1192/s0007125000139856 · Cited by 42
[Mortality and cause of death in schizophrenia. Review of the literature].
Tabbane, K., Joober, R., Spadone, C., Poirier, M. F., & Olié, J. (1993) · PubMed · Cited by 31
Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons.
Rasmussen, K., & Czachura, J. F. (1995) · PubMed · Cited by 29
Schulz, D. W., Kuchel, G. A., & Zigmond, R. E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07463.x · Cited by 26
ABT-418: discriminative stimulus properties and effect on ventral tegmental cell activity
Brioni, J. D., Kim, D. J. B., Brodie, M. S., Decker, M. W., & Arnerić, S. P. (1995) · Psychopharmacology · doi:10.1007/bf02245851 · Cited by 23
Mirza, N. R., Pei, Q., Stolerman, I. P., & Zetterström, T. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00749-0 · Cited by 22
Abdulla, F. A., Calaminici, M., Wonnacott, S., Gray, J. A., Stephenson, J. D., & Sinden, J. D. (1995) · Synapse · doi:10.1002/syn.890210402 · Cited by 21
Liu, C., Nordberg, A. K., & Zhang, X. (1996) · Neuroreport · doi:10.1097/00001756-199607080-00024 · Cited by 14
Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons
Rasmussen, K., & Czachura, J. F. (1995) · Neuroreport · doi:10.1097/00001756-199512000-00079 · Cited by 4
Cited by
Braff, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,705
de Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276
“, 1998; de Leon et al., 2002b) and one in Israel (Itkin et al., 2001) did not find significant differences in the mean FTND scores of schizophrenia versus mood-disordered smokers from same treatment settings. de Leon et al. (2002c) studied high nicotine dependence (FTND≥6) in samples of severely mentally ill smokers a…”
BackgroundMethodAntipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death
Glassman, A. H., & Bigger, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1774 · Cited by 822
Co‐Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders
Kalman, D., Morissette, S. B., & George, T. P. (2005) · The American Journal on Addictions · doi:10.1080/10550490590924728 · Cited by 594
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum
Zhou, F.-M., Liang, Y., & Dani, J. A. (2001) · Nature Neuroscience · doi:10.1038/nn769 · Cited by 585
Metadata
- Authors
- Dalack, G. W., Healy, D. J., & Meador-Woodruff, J. H.
- Venue
- American Journal of Psychiatry
- Published
- 1998-11-01
- Volume
- 155
- Issue
- 11
- Pages
- 1490-1501
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2149445681
- Cited by
- 498
- References
- 92
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.